<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00570544</url>
  </required_header>
  <id_info>
    <org_study_id>1000</org_study_id>
    <secondary_id>Boehringer-Ingelheim Pharm.</secondary_id>
    <secondary_id>Pfizer</secondary_id>
    <nct_id>NCT00570544</nct_id>
  </id_info>
  <brief_title>Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema</brief_title>
  <official_title>Effectiveness of Tiotropium to Maintain Inspiratory Capacity Against Metronome Paced Hyperventilation Induced Dynamic Hyperinflation in COPD Patients With Lung CT Scored Emphysema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gelb, Arthur F., M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Gelb, Arthur F., M.D.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate if tiotropium (Spiriva)induced bronchodilation of inspiratory capacity in
      patients with moderate to severe copd subjected to metronome paced hyperventilation induced
      dynamic hyperinflation is dependent upon the extent of underlying emphysema as determined by
      high resolution-thin section CT lung.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will analyze post hoc, data that was previously published: Gelb AF et al.Chest
      2006;131:690-695. We have shown that tiotropium increases resting inspiratory capacity
      thereby providing lung volume protection against metronome paced hyperventilation induced
      dynamic hyperinflation. End point will be to correlate increase in tiotropium induced FEV
      1(L) and inspiratory capacity with extent of underlying emphysema as scored by lung CT ( Gelb
      AF et al:Chest 1996; 109: 353-359)in 29 patients with COPD. We will also correlate the
      decrease in inspiratory capacity following metronome paced hyperventilation induced dynamic
      hyperinflation with extent of lung CT scored emphysema.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">August 2005</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlate tiotropium induced increase in inspiratory capacity (IC)and FEV 1 with extent of emphysema as scored by lung CT.</measure>
    <time_frame>After 30 days and 1.5hr of tiotropium</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlate decrease in IC and FEV 1 following dynamic hyperinflation with underlying emphysema.</measure>
    <time_frame>After 30 days and 1.5hr of tiotropium</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">29</enrollment>
  <condition>COPD</condition>
  <condition>Emphysema</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>patients with moderate to severe copd with varying extent of emphysema</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tiotropium</intervention_name>
    <description>18ug capsule daily for 30 days</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Spiriva</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with moderate to severe copd from tertiary care pulmonary clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  moderate to severe copd

        Exclusion Criteria

          -  unable to tolerate tiotropium

          -  unable to perform metronome paced hyperventilation induced dynamic hyperinflation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arthur F Gelb, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arthur F Gelb Medical Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arthur F Gelb Medical Corporation</name>
      <address>
        <city>Lakewood</city>
        <state>California</state>
        <zip>90712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gelb AF, Taylor CF, McClean PA, Shinar CM, Rodrigues MT, Gutierrez CA, Chapman KR, Zamel N. Tiotropium and simplified detection of dynamic hyperinflation. Chest. 2007 Mar;131(3):690-695. doi: 10.1378/chest.06-1662.</citation>
    <PMID>17356081</PMID>
  </reference>
  <reference>
    <citation>Gelb AF, Hogg JC, MÃ¼ller NL, Schein MJ, Kuei J, Tashkin DP, Epstein JD, Kollin J, Green RH, Zamel N, Elliott WM, Hadjiaghai L. Contribution of emphysema and small airways in COPD. Chest. 1996 Feb;109(2):353-9.</citation>
    <PMID>8620705</PMID>
  </reference>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2007</study_first_submitted>
  <study_first_submitted_qc>December 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2007</study_first_posted>
  <last_update_submitted>August 13, 2008</last_update_submitted>
  <last_update_submitted_qc>August 13, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 14, 2008</last_update_posted>
  <responsible_party>
    <name_title>Arthur F Gelb MD</name_title>
    <organization>Arthur F Gelb Medical Corporation</organization>
  </responsible_party>
  <keyword>copd</keyword>
  <keyword>emphysema</keyword>
  <keyword>tiotropium</keyword>
  <keyword>lung function</keyword>
  <keyword>dynamic hyperinflation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tiotropium Bromide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

